Trials / Completed
CompletedNCT05269511
Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts
Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,163 (actual)
- Sponsor
- Hong Kong Baptist University · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, blank-controlled study in adults with household contact exposure to individuals with SARS-CoV-2 infection. All subjects in the study will be household contacts with close exposure to the first household member known to be newly infected with SARS-CoV-2. Subjects in each cohort will be randomly assigned to the Chinese herbal medicine treatment group or blank control group in a 4:1 ratio, followed by 1 week of the treatment period and 2 weeks of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs. | Oral administration, twice per day. |
Timeline
- Start date
- 2022-03-14
- Primary completion
- 2022-06-22
- Completion
- 2022-06-22
- First posted
- 2022-03-08
- Last updated
- 2023-04-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05269511. Inclusion in this directory is not an endorsement.